{
    "eid": "2-s2.0-85138056518",
    "title": "Association of single and serial measures of serum phosphorus with adverse outcomes in patients on peritoneal dialysis: results from the international PDOPPS",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Transplantation",
            "@code": "2747",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "hyperphosphatemia",
        "mace",
        "mortality",
        "peritoneal dialysis",
        "phosphorus"
    ],
    "authors": [
        "Marcelo Barreto Lopes",
        "Angelo Karaboyas",
        "Junhui Zhao",
        "David W. Johnson",
        "Talerngsak Kanjanabuch",
        "Martin Wilkie",
        "Kosaku Nitta",
        "Hideki Kawanishi",
        "Jeffrey Perl",
        "Ronald L. Pisoni",
        "David Johnson",
        "Jeffrey Perl",
        "Mauricio Sanabria",
        "Hideki Kawanishi",
        "Yong Lim Kim",
        "Talerngsak Kanjanabuch",
        "Simon Davies",
        "Ronald Pisoni",
        "Bruce Robinson",
        "Jenny Shen"
    ],
    "citedby-count": 5,
    "ref-count": 25,
    "ref-list": [
        "Mortality risk for dialysis patients with different levels of serumcalcium, phosphorus, and PTH: the DialysisOutcomes and Practice Patterns Study (DOPPS)",
        "Mineral metabolism, mortality, and morbidity in maintenance hemodialysis",
        "Impact of longer termphosphorus control on cardiovascular mortality in hemodialysis patients using an area under the curve approach: results from the DOPPS",
        "ISPD guideline/ recommendations: a syllabus for teaching peritoneal dialysis to patients and caregivers",
        "KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)",
        "Phosphorus metabolism in peritoneal dialysis-and haemodialysis-treated patients",
        "Associations between serum mineral metabolism parameters and mortality in patients on peritoneal dialysis",
        "The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): unifying efforts to informpractice and improve global outcomes in peritoneal dialysis",
        "A new look at the statistical model identification",
        "Spontaneous variability of predialysis concentrations of uremic toxins over time in stable hemodialysis patients",
        "Variability of laboratory parameters is associated with frailty markers and predicts noncardiac mortality in hemodialysis patients",
        "The effect of dialyzer membrane and etiology of kidney disease on the preservation of residual renal function in chronic hemodialysis patients",
        "Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers",
        "Phosphate removal by peritoneal dialysis: the effect of transporter status and peritoneal dialysis prescription",
        "Phosphate equilibration rate and daily clearance in patients on CAPD, CCPD and APD",
        "Phosphate clearance in peritoneal dialysis",
        "Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study",
        "Low serum potassium levels and clinical outcomes in peritoneal dialysis-international results from PDOPPS",
        "Independent effects of residual renal function and dialysis adequacy on dietary micronutrient intakes in patients receiving continuous ambulatory peritoneal dialysis",
        "Predictors of decline of residual renal function in new peritoneal dialysis patients",
        "Global prevalence of protein-energy wasting in kidney disease: a meta-analysis of contemporary observational studies fromthe International Society of RenalNutrition andMetabolism",
        "Cross sectional analysis of D/P creatinine ratios versus serum albumin values in NIPD patients",
        "Phosphate levels-time for a rethink?"
    ],
    "affiliation": [
        {
            "affiliation-city": "Hiroshima",
            "@id": "60254871",
            "affilname": "Tsuchiya General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60254871",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Ann Arbor",
            "@id": "60136265",
            "affilname": "Arbor Research Collaborative for Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60136265",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Woolloongabba",
            "@id": "60109259",
            "affilname": "Translational Research Institute Australia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60109259",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Brisbane",
            "@id": "60031004",
            "affilname": "The University of Queensland",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031004",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Tokyo",
            "@id": "60025639",
            "affilname": "Tokyo Women's Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025639",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Woolloongabba",
            "@id": "60025258",
            "affilname": "Princess Alexandra Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025258",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Sheffield",
            "@id": "60024453",
            "affilname": "Sheffield Teaching Hospitals NHS Foundation Trust",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024453",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60017018",
            "affilname": "Saint Michael's Hospital University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017018",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Akebia Therapeutics, Inc."
    ]
}